Welcome New Corporate Partners: Hologic, Inc. and MiMedx Group, Inc.

Please join us in welcoming the following new corporate partners contributing their support to the HBA mission.


Hologic, Inc.
CEO: Stephen P. MacMillan
Hologic is a global medical technology company specializing in women’s health—offering innovative solutions for screening, detecting and treating conditions affecting women throughout their lives, including breast and cervical cancer testing, gynecological and skeletal issues; and sexually transmitted diseases.


MiMedx Group, Inc.
CEO: Timothy R. Wright
MiMedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied over 1.9 million allografts, through both direct and consignment shipments.

Interested in becoming a corporate partner? Explore the value of partnership with the HBA and view the latest packages.